Imperial Innovations Group Regulatory News (IVO)

14 Jun 2007 14:31

Imperial Innovations Group plc14 June 2007 Imperial Innovations Group plc ("Imperial Innovations") Investment in Midaz Lasers Ltd Imperial Innovations Group plc (AIM: IVO), the technology commercialisation andinvestment company, today announces that it has subscribed £112,595.32 forfurther shares in Midaz Lasers Ltd, ("Midaz Lasers"), a company that developslasers for industrial markets. The rights issue in Midaz Lasers is part of a£225,190.64 seed funding round that also includes a £112,595.32 investment fromDr. Paul Atherton. Dr. Atherton, who is a Non-executive Director of ImperialInnovations Group plc, is also the Executive Chairman of Midaz Lasers. -Ends- For more information contact: Imperial InnovationsSusan Searle, Chief Executive Officer +44 (0)20 7594 6591Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644 M:Communications +44 (0)20 7153 1539Patrick d'Ancona / Eleanor Williamson JPMorgan Cazenove +44 (0)20 7588 2828Steve Baldwin Notes to Editors About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £26 million. The company's integrated approach encompassesthe identification of ideas, protection of intellectual property, developmentand licensing of technology and formation, incubation and investment intechnology businesses. A wide range of technologies are commercialised withinthe areas of healthcare, energy, environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in70 technology businesses and has completed 116 commercial agreements. ImperialInnovations also commercialises technologies originating from outside ImperialCollege through incubation contracts with the Carbon Trust and WRAP and hasrelationships with a number of multinational corporations including BAE Systems. Imperial Innovations has invested in a range of spin-out companies, includingThe Acrobot Company Limited, BioCeramic Therapeutics Limited, Cardiak Limited,Circassia Holdings Limited, deltaDOT Limited, Equinox Pharma Limited, FutureWaves PTE Limited, HeliSwirl Technologies Limited, InforSense Limited, IXICOLimited, Lontra Limited, Midaz Lasers Limited, NanoBioDesign Limited, NexeonLimited, NovaThera Limited, Thiakis Limited and Veryan Medical Limited. Imperial Innovations currently holds shares in four technology businesses nowlisted on AIM including the fuel cell company, Ceres Power plc. www.imperialinnovations.co.uk About Midaz Lasers Midaz Lasers Ltd manufactures an innovative range of diode-pumped solid state(DPSS) lasers based on proprietary technology providing a breakthrough in laserperformance. Midaz technology offers an unparalleled combination of increasedefficiency, ultra-compact size, whilst simultaneously offering high power,almost perfect beam quality and high peak power pulsed operation. The uniqueproperties of the Midaz technology also enable Midaz to be the only supplier ofQ-switched DPSS lasers with MHz pulse rates. Applications are diverse, but Midazproducts will be particularly beneficial in industrial micromachining processeswhere speed and the highest quality are desirable. This information is provided by RNS The company news service from the London Stock Exchange